Taipei Exchange - Delayed Quote TWD

Prince Pharmaceutical Co., Ltd. (6935.TWO)

20.90
-0.25
(-1.18%)
As of 11:25:38 AM GMT+8. Market Open.

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Da Li GM & Chairman -- -- --
Cuiwei Chen Accounting Supervisor -- -- --

Prince Pharmaceutical Co., Ltd.

No.168, Keyun S. Road
Huwei Township
Yunlin County, 632
Taiwan
886 5 632 6910 https://www.prince-pharm.com.tw
Sector: 
Healthcare
Full Time Employees: 
210

Description

Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally. The company also offers health food and medicines; vitamin c tablets, vitamin b complex tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. It supplies its products to Spain and Europe. Prince Pharmaceutical Co., Ltd. was founded in 1962 and is headquartered in Yunlin County, Taiwan.

Corporate Governance

Prince Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

June 21, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers